IRVINE, Calif., July 6, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the acquisition of the company by C. R. Bard, Inc. (NYSE:BCR) was completed today. Under the terms of the merger agreement, SenoRx stockholders will receive $11 in cash for each share held of SenoRx common stock, a premium of approximately 14 percent over the closing price of SenoRx shares on May 4, 2010, the last trading day before the public announcement of the acquisition, and a premium of approximately 41 percent over the average closing price of SenoRx shares during the 90 trading days ended May 4, 2010. With the closing of the transaction, trading in SenoRx common shares was suspended before market open this morning. SenoRx common shares will cease to trade on NASDAQ at market close today and will be delisted.
